Restenosis following percutaneous transluminal angioplasty: Clinical, physiologic and pathological features

J. L. Cox, A. I. Gotlieb

Research output: Contribution to journalReview articlepeer-review

13 Scopus citations

Abstract

Percutaneous transluminal coronary angioplasty (PTCA) has been used clinically for 8 years and is becoming widely accepted in the treatment of atherosclerotic coronary artery disease. Since the long-term effects of the procedure are unknown, the rate of restenosis following the procedure, approximately 30% is of major concern. We briefly review the current status of PTCA and the effect of angioplasty on the vessel wall and discuss proposed mechanisms of recurrent stenosis.

Original languageEnglish
Pages (from-to)1129-1132
Number of pages4
JournalCanadian Medical Association journal
Volume134
Issue number10
StatePublished - Jan 1 1986

Fingerprint

Dive into the research topics of 'Restenosis following percutaneous transluminal angioplasty: Clinical, physiologic and pathological features'. Together they form a unique fingerprint.

Cite this